PBSS Boston, September 9th, 2026

Join Pharmaron at PBSS Boston, September 9th, 2026

Pharmaron is proud to sponsor the Boston Pharmaceutical & Bioscience Society (PBSS) event, “IND Filing and Nonclinical Considerations for Emerging Modalities: Protein Degraders, Oral Peptides, and Oligonucleotide Conjugates,” taking place on September 9, 2026, from 8:45 AM to 5:00 PM ET at Bristol Myers Squibb in Cambridge, Massachusetts.

Event Details:

September 9th, 2026
8:45 AM to 5:00 PM ET
Bristol Myers Squibb in Cambridge, Massachusetts

Successful IND-enabling strategies require a deep understanding of the unique nonclinical, bioanalytical, and regulatory considerations associated with these complex drug candidates, as the industry continues to advance innovative therapeutic modalities. This event will bring together industry experts to discuss the challenges and opportunities surrounding the development of protein degraders, oral peptides, and oligonucleotide conjugates.

Connect with us

Be sure to connect with Pharmaron’s scientific and business development team during the event:

Thomas Kelm, Senior Director, CGT and Biologics Bioanalysis
Chelsea Osbrey, MS, Senior Director, Business Development, 14C/3H Radiolabelling Services

Whether you are advancing a discovery-stage program, or preparing for IND submission, Pharmaron offers integrated solutions spanning discovery, DMPK, bioanalysis, toxicology, 14C/3H radiolabelling, CMC, and regulatory support to help accelerate your development timelines.

Schedule a meeting with our team during the event to discuss your upcoming projects and learn how Pharmaron can support your program success.

Schedule a Meeting Below Using the Form

Our PBSS Boston Schedule

Talks and Posters

Thomas Kelm will present at 10 AM during the scientific program. Presentation details will be released soon.

About the PBSS Boston Workshop on IND Filing and Nonclinical Considerations for Emerging Modalities: Protein Degraders, Oral Peptides, and Oligonucleotides

Protein degraders, oral peptides, and oligonucleotide conjugates are novel therapeutic modalities. This makes their IND-enabling packages harder to build. This workshop walks through the nonclinical strategy for these modalities, with a focus on the pharmacokinetics and toxicology questions they raise. For more information and event registration, please visit the PBSS Website.

Complete this form to Request a Meeting

Meeting Request Form

Meeting requests during a conference or event

Name(Required)

First Last

Company Name(Required)

Job Title

Email(Required)

What services would you like to discuss?(Required)

What time of the day works best for you (morning, afternoon, or evening)?(Required)

Which day or days of the conference are best for you to meet? If you need a specific date and time window, make a note here.

By completing and submitting this form, you acknowledge that you have read and understood our Privacy Policy, and you consent to the collection and processing of your personal data by Pharmaron for the purpose of responding to your inquiry. You also agree to be contacted by Pharmaron regarding relevant services and updates. You may withdraw your consent at any time.